CaP Biomaterials

CaP Biomaterials manufactures calcium phosphate materials that can be incorporated into many types of medical devices by medical device manufacturers. Because of diversity of applications it is CaP Biomaterial’s policy to work with customers in the process of choosing the calcium phosphate product requirements/specifications. This often results in supplying a customized product exactly suited to the end use.

CaP and customer come to agreement on material requirements and preparedraft product specifications.

read more

watch the video

Hydroxyapatite porous granulate

Decide if an existing material is suitable or a custom material is needed.


  • Porous granulates of:
    • Hydrxyapatite
    • Tricalcalcium phsphate
    • Mixtures f hydroxyapatite and tricalcium phosphate
  • Hydroxyapatite powder for plasma spraying
  • Calcium phosphate powders of many different compositions for incorporation into polymers
  • Metastable calcium phosphate powders (tetracalcium phosphate; alpha-TCP) for producing self-setting cements
  • Finished self-setting cement powder

CaP Biomaterials prepares/supplies development samples so customer can test the concept.

CaP carries out extensive testing on the prototype product including:

  • XRD analysis for phase composition
  • optical image analysis for pore size, porosity, and particle size
  • surface area analysis (if requested)
  • dissolution and/or solubility (if requested)
  • trace metals analysis


read more

Product specifications are discussed with customer and may be revised.

Prepare batches for customer to use in their process/product validation (if requested).


  • Hydroxyapatite coated implant
  • Collagen strip with ceramic particles
  • Putty with ceramic particles
  • Tray package filled with ceramic particles

read more

watch the video

Go to article: Home | For Sale: Med Tech MalwareGo to article: In This Issue Go to article: Formacoat Company InsightGo to article: FormacoatGo to article: Contents Go to article: MPS Microsystems Company InsightGo to article: MPS MicrosystemsGo to article: NewsGo to article: Cap Biomaterials Company Insight Go to article: Cap BiomaterialsGo to article: Protomatic Medical Company InsightGo to article: Protomatic MedicalGo to article: The Medical Industry Briefing Go to article: Telemed Company InsightGo to article: TelemedGo to article: Under the skin: the medical device industry and the dark webGo to article: Braxton Manufacturing Go to article: ARPA Company InsightGo to article: ARPAGo to article: AI and open sourcing: a new frontier for prosthetic leg designGo to article: Ginolis Company InsightGo to article: GinolisGo to article: Accurate BiometricsGo to article: Accurate Biometrics Company InsightGo to article: The age of the autonomous pharmacy Go to article: Sandvik Company InsightGo to article: Sandvik Go to article: Q&A: LifeBank on the challenge of getting blood from A to B in Nigeria Go to article: Mecmesin Company InsightGo to article: MecmesinGo to article: 5G meets medicine: separating fact from fictionGo to article: Maraca InternationalGo to article: Adhesives ResearchGo to article: Meril Life Sciences: leading a growing Indian medtech sectorGo to article: PI CeramicGo to article: Erdmann Design Go to article: Making electronic health records workGo to article: Thermal Press InternationalGo to article: Euroquartz Company InsightGo to article: EuroquartzGo to article: Snooze, you lose: the devices helping to understand the science of sleepGo to article: OptelGo to article: US makes strides in below-the-knee use of drug-coated balloonsGo to article: 3BYGo to article: Continuous glucose monitoring is quickly becoming standard-of-care for diabetes Go to article: Bright PlasticsGo to article: Bariatric surgery is driving factor for medical tourismGo to article: Art of TechnologyGo to article: Opportunities and challenges in China’s wound care marketGo to article: Tech NHGo to article: Bayer AG acquires BlueRock TherapeuticsGo to article: EventsGo to article: Next Issue